Key statistics
On Tuesday, CARsgen Therapeutics Holdings Ltd (2171:HKG) closed at 12.18, 23.03% above the 52 week low of 9.90 set on Apr 09, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 12.26 |
|---|---|
| High | 12.80 |
| Low | 12.10 |
| Bid | -- |
| Offer | -- |
| Previous close | 12.26 |
| Average volume | 1.84m |
|---|---|
| Shares outstanding | 570.31m |
| Free float | 352.37m |
| P/E (TTM) | -- |
| Market cap | 8.06bn HKD |
| EPS (TTM) | -1.09 HKD |
Data delayed at least 15 minutes, as of Mar 03 2026 08:08 GMT.
More ▼
Press releases
- CARsgen Signs Strategic Cooperation Agreements to Expand CAR-T Commercial Manufacturing Base in Jinshan, Shanghai
- CARsgen and Dispatch Bio Announce Clinical Collaboration to Evaluate Flare Platform and Zevor-cel in Solid Tumors
- CARsgen Submits Dual IND Applications for Allogeneic BCMA CAR-T Product CT0596
- CARsgen Announces Data of Allogeneic BCMA CAR-T Cell Therapy CT0596 for Relapsed/Refractory Multiple Myeloma at the 2025 ASH Annual Meeting
- CARsgen Announces Data of Allogeneic BCMA CAR-T Cell Therapy CT0596 for Relapsed/Refractory Multiple Myeloma at the 2025 ASH Annual Meeting
- CARsgen's CAR-T Product Zevor-Cel Included in China's Commercial Health Insurance Innovative Drug Catalogue
More ▼
